Literature DB >> 33152097

Non-traditional factors affecting referral for coronary angiography following SPECT myocardial perfusion imaging.

Shreyas Gowdar1, Nasir Hussain1, Alan W Ahlberg1, Mohammad Elsadany1, Guru N Kowlgi2, David Silverman1, W Lane Duvall3.   

Abstract

BACKGROUND: The use of myocardial perfusion imaging (MPI) in the management of coronary artery disease (CAD) is well established. Although prior studies have shown disparities in the use of invasive angiography in patients with acute MI, data on factors affecting referral to angiography post-MPI are lacking. We sought to evaluate the primary determinants of referral to invasive angiography post-MPI and specifically assess the role of non-traditional non-clinical factors such as race/ethnicity, socioeconomic factors, insurance status, and marital status.
METHODS: All patients without known CAD who underwent stress SPECT MPI over 15 years were reviewed and the performance of coronary angiography within 90 days of their MPI was recorded. Multiple factors were analyzed for an association with referral to angiography, including exercise and MPI results, baseline demographics, traditional cardiac risk factors, and non-traditional factors such as ethnicity, insurance, marital and socioeconomic status. In a secondary analysis, these factors were assessed with regard to abnormal MPI results.
RESULTS: Out of 27,895 total patients, 2,150 (7.7%) underwent invasive coronary angiography. On multivariate analysis, inpatient location, positive ECG response, and abnormal MPI results were the strongest predictors of angiography. Non-traditional factors such as race/ethnicity and insurance status had a significant association with referral to angiography with Caucasians (OR 1.42, 95% CI 1.18-1.71, P < .0001) and those with private insurance (OR 1.35, 95% CI 1.13-1.62, P = .001) or Medicare (OR 1.30, 95% CI 1.08-1.56, P = .006) having higher rates of angiography despite controlling for traditional risk factors and test results.
CONCLUSION: Our study results indicate that non-traditional factors such as race/ethnicity and insurance status influence patient management decisions and impact the performance of downstream cardiac invasive testing after stress MPI. Higher rates of angiography in Caucasians, privately insured and Medicare patients were seen despite controlling for traditional risk factors and abnormal test results. Further research is needed to better understand these disparities, especially in the current healthcare environment.
© 2020. American Society of Nuclear Cardiology.

Entities:  

Keywords:  Coronary angiography; Ethnicity; Insurance status; Myocardial perfusion imaging; Race

Mesh:

Year:  2020        PMID: 33152097     DOI: 10.1007/s12350-020-02419-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  4 in total

1.  Is coronary angiography underused in an inner-city population?

Authors:  Janice Barnhart; Steven J Bernstein
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

2.  Disparities by insurance status in quality of care for elderly patients with unstable angina.

Authors:  Salpy V Pamboukian; Ellen Funkhouser; Ian G Child; Jeroan J Allison; Norman W Weissman; Catarina I Kiefe
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

3.  Racial and ethnic disparities in cardiac catheterization for acute myocardial infarction in the United States, 1995--2001.

Authors:  Alain G Bertoni; Kelly L Goonan; Denise E Bonds; Melicia C Whitt; David C Goff; Frederick L Brancati
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

4.  Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease.

Authors:  Angela S Koh; Fei Gao; C T Chin; Felix Y J Keng; Ru-San Tan; Terrance S J Chua
Journal:  J Nucl Cardiol       Date:  2015-09-11       Impact factor: 5.952

  4 in total
  1 in total

1.  Is faster always better? What is the implication of a shorter time to imaging with tetrofosmin compared to sestamibi?

Authors:  Kelly Laipply; Myron Gerson
Journal:  J Nucl Cardiol       Date:  2020-05-13       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.